Jamey Lister

Jamey Lister, PhD (Rutgers University, 2014), is an associate professor at Rutgers, The State University of New Jersey within the School of Social Work. Dr. Lister’s addiction scholarship targets solutions for medically underserved populations. He emphasizes identifying practical treatment and policy implications, strategies to promote access to evidence-based care, and methods that foster health equity. Dr. Lister’s teaching, community partnerships, and research dissemination all center on improving clinical practice across sectors. He studies opioid use disorder, other addictions, and behavioral health disorders. Having grown up in a rural, medically underserved, mental health professional shortage area of Michigan guides Dr. Lister’s scholarship and intention to promote trust with partners.

Dr. Lister has led and collaborated on projects funded by the U.S. Department of Health and Human Services (HHS) (e.g., SAMHSA, HRSA), philanthropic foundations, and university funded initiatives; has received awards from the National Institute on Drug Abuse, College on Problems of Drug Dependence, and U.S. Fulbright Program; and engages in service for scientific outlets, community health and social work organizations, and academic institutions. His research studies apply diverse designs to interpret multiple methods data from patients, providers, medical records, and public health measures. Dr. Lister’s leadership development includes being Key Personnel (Site Principal Investigator, Lead Evaluator) on large-scale health care projects funded by HHS awards totaling more than $17.5 million, on which he has directed, as Site PI, more than $2 million in federal funds. In the latter role, Dr. Lister oversees a team of Co-Is, staff, and students to collaboratively engage with partners from outside universities, disciplines, and sectors. He also currently serves as the Co-Director and New Jersey Director of SAMHSA's Northeast & Caribbean Rural Opioid Technical Assistance Center and was part of the inaugural cohort for the Rutgers University Equity and Inclusion Identity and Leadership Program.

Before joining the faculty at Rutgers University, Dr. Lister was at Wayne State University as a tenure-track faculty member, and prior to that, as a postdoctoral fellow. He earned his PhD from Rutgers University, MSW from the University of Michigan, and BS from Miami (Ohio) University. Dr. Lister’s full-time faculty positions, and each educational institution he earned degrees from, have been in social work programs at public research universities. Conversely, much of Dr. Lister’s training and collaborations involve partnerships with other disciplines (e.g., psychiatry, psychology, public health) and organizations (e.g., academic medical center sites, state health care systems, community-based) engaged in clinical practice for addiction.

• Reducing Drug Harm: Social Work Practice & Policy (19:910:570 (starting 2025)
• Case Management in Addictions Practice (19:910:598)
• HBSE: Understanding Addictive Behaviors (19:910:514)
• Clinical Assessment & Diagnosis (19:910:507)
• Clinical Social Work II (19:910:512)
• Advanced Individual Studies in Social Welfare (19:910:682

Selected First-Author Publications in Refereed Journals (students & postdocs marked with asterisk):

Lister, J.J., & Joudrey, P.J. (2023). Rural mistrust of public health interventions in the United States: A call for taking the long view to improve adoption. The Journal of Rural Health, 39(1), 18-20. Doi: 10.1111/jrh.12684

Lister, J.J., Lister, H.H., Powell, K.G., *Cheung, S.P., Peterson, N.A., Toto, A.M., & Marcello, S.C. (2024). The Rutgers Integrated Care Evaluation (RICE) Research Framework: An innovative and rigorous set of methods to evaluate integrated care programs. International Journal of Integrated Care, 24(3): 22, 1-8. DOI: 10.5334/ijic.7715

Lister, J.J., Weaver, A., *Ellis, J.D., Himle, J.A., & Ledgerwood, D.M. (2020). A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. The American Journal of Drug and Alcohol Abuse, 46(3), 273-288. Doi: 10.1080/00952990.2019.1694536

Lister, J.J., *Ellis, J.D., *Struble, C.A., Ledgerwood, D.M., & Greenwald, M.K. (2024). Protective factor predictors of abstinence and retention in patients receiving methadone treatment for opioid use disorder. International Journal of Mental Health and Addiction, 22, 615-633. Doi: 10.1007/s11469-022-00893-z

Lister, J.J., & Lister, H.H. (2021). Improving methadone access for rural communities in the USA: Lessons learned from COVID-19 adaptations and international models of care. Rural and Remote Health, 21(4), 6770. Doi: 10.22605/RRH6770

Lister, J.J., *Ellis, J.D., & *Yoon, M. (2020). Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013-2017. Addictive Behaviors Reports, 11, 100234, 1-8. Doi: 10.1016/j.abrep.2019.100234

Lister, J.J., *Lee, G., *Ellis, J.D., *Pasman, E., Agius, E., & Resko, S.M. (2022). Comorbid affective and substance use disorders of Medicaid/Medicare beneficiaries at an opioid treatment program serving small urban and rural communities. Frontiers in Psychiatry, 13, 881821, 1-9. Doi: 10.3389/fpsyt.2022.881821

Lister, J.J., Brown, S., Greenwald, M.K., & Ledgerwood, D.M. (2019). Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic. Substance Abuse, 40, 185-193. Doi: 10.1080/08897077.2018.1547810

Lister, J.J., Greenwald, M.K., & Ledgerwood, D.M. (2017). Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone. Journal of Substance Use and Addiction Treatment, 78, 15-21. Doi: 10.1016/j.jsat.2017.04.007

Lister, J.J., *Yoon, M., Nower, L., *Ellis, J.D., & Ledgerwood, D.M. (2022). Subtypes of patients with opioid use disorder in methadone maintenance treatment: A pathways model analysis. International Gambling Studies, 22(2), 300-316. Doi: 10.1080/14459795.2022.2044502

Selected Co-Author Publications in Refereed Journals (students & postdocs marked with asterisk):

Lloyd, J., *Treitler, P., Lister, J.J., *Nowels, M., & Crystal, S.C. (2024). Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic. Journal of Substance Use and Addiction Treatment, 167, 209476. Doi: 10.1016/j.josat.2024.209476

*Struble, C.A., Lister, J.J., *Urbiel, J., Nyaku, A.N., & Arfken, C.L. (2022). Comparisons of injection and non-injection opioid use among Black people in methadone treatment: A pilot in Detroit. Addictive Behaviors, 126, 107182, 1-5. Doi: 10.1016/j.addbeh.2021.107182

*Pasman, E., Kollin, R., *Broman, M., *Lee, G., Agius, E., Lister, J.J., Brown, S., & Resko, S.M. (2022). Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addiction Science & Clinical Practice, 17, 35, 1-10. Doi: 10.1186/s13722-022-00316-3

Lister, H.H. Marcello, S., Lister, J.J., Toto, A.M., Powell, K.G., Peterson, N.A. (2022). Advancing the behavioral health workforce: An innovative integrated care and substance use disorder training model to improve outcomes for people in medically underserved communities. Families, Systems, & Health, 40(4), 586-591. Doi: 10.1037/fsh0000739

Ware, O.D., Lee, K.A., Lombardi, B., Buccio, D.L., Lister, J.J., Park, E., Estreet, A., Van Denise, T., Neukrug, H., Blank Wilson, A., Park, D., & Lanier, P. (2024). Artificial neural network analysis examining substance use problems co-occurring with anxiety and depressive disorders among adults receiving mental health treatment. Journal of Dual Diagnosis, 1-12. Doi: 10.1080/15504263.2024.2357623

*Crowthers, R.A., *Arya, M., Venkataraman, A., Lister, J.J., *Cooper, S.E., *Enich, M., Bender, E., Stevens, S., Sanders, R., Stagliano, K., & Jermyn, R.T. (2022). Impact of an osteopathic peer recovery coaching model on treatment outcomes in high-risk men entering residential treatment for substance use disorders. Journal of Osteopathic Medicine, 122(10), 521-529. Doi: 10.1515/jom-2022-0066

*Milano, N., Lister, J.J., & Victor, G. (2023). Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross-lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid use disorder. The American Journal on Addictions, 32, 352-359. Doi: 10.1111/ajad.13392

*Sogbesan, A., Lenz, D., Lister, J.J., Lundahl, L.H., Greenwald, M.K., & Woodcock, E.A. (2024). Mediational pathways among drug use initiation, use-related consequences, and quit attempts. Drug and Alcohol Dependence Reports, 11, 100229, 1-7. Doi: 10.1016/j.dadr.2024.100229

*Carl, A., *Pasman, E., *Broman, M., Lister, J.J., Agius, E., & Resko, S.M. (2023). Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone. Drug and Alcohol Dependence Reports, 6, 100138, 1-7. Doi: 10.1016/j.dadr.2023.100138

Victor, G., *Hedden, B.J., Lister, J.J., *Lee, G., Huynh, P., & Ray, B. (2023). Community overdose surveillance: Fentanyl involvement in overdose deaths in rural Michigan. Drug and Alcohol Dependence Reports, 7, 100150, 1-7. Doi: 10.1016/j.dadr.2023.100150